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Background: Blastocystis is a common single-celled intestinal parasite of humans and other animals comprising at
least 17 genetically distinct small subunit ribosomal RNA lineages (subtypes (STs)), nine of which have been found
in humans. The geographic distribution of Blastocystis subtypes is variable, but the subtypes present in Qatar are at
present unknown.
Methods: Stool samples were collected from randomly selected, apparently healthy subjects arriving in Qatar for
the first time. Blastocystis subtypes were determined by sequencing of the small subunit rRNA gene (SSU rDNA)
PCR products. Phylogenetic analyses were done using Maximum Composite Likelihood method.
Results: 71.1 % of samples were positive for Blastocystis infection based on PCR-detection methodology compared
to only 6.9 % by microscopy. Prevalence of Blastocystis did not differ between the sexes nor between age classes.
However, there was a regional difference in prevalence with subjects arriving from Africa showing the highest
(87.6 %), those from Western Asia intermediate (68.6 %) and from Eastern Asia the lowest prevalence (67.6 %).
Genetic analysis detected only three STs. ST3 was the most common (69.3 %) and ST2 was the rarest (3.5 %), while
ST1 had a prevalence of 27.2 %. ST2 showed a regional variation, being absent from the 64 Western Asian
Blastocystis-positive subjects. Both ST1 and ST3 showed significant differences in prevalence between the sexes.
Conclusions: This is the first report exploring the distribution of Blastocystis subtypes in our region. We recommend
that stool screening via microscopy for the presence of Blastocystis should be abandoned since it is extremely
insensitive. In future, the prevalence of Blastocystis infections should be based on PCR methodology and we predict
that in the years ahead diagnostic PCR will become the tool of choice. More work is needed to identify the full
range of Blastocystis subtypes that circulate in our region.
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Blastocystis is a single-celled intestinal protist, taxonom-
ically placed within the Stramenopiles, which colonizes
an estimated 1,000,000,000 people globally and a variety
of animal species [1]. Although Blastocystis is also de-
tected in asymptomatic humans [2], some studies link
this organism with intestinal and extra-intestinal disease
[3, 4]. To date, despite Blastocystis being the most fre-
quently isolated protist from diarrheal patients in the de-
veloped world, a causal link has not yet been established
conclusively [5]. Blastocystis is genetically diverse and* Correspondence: abumadi@qu.edu.qa
1Department of Health Sciences, College of Arts and Science, Biomedical
Research Center, Qatar University, P.O. Box 2713, Doha, Qatar
Full list of author information is available at the end of the article
© 2015 Abu-Madi et al. Open Access This art
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zebased on small subunit rRNA gene analysis (SSU rDNA),
at least 17 subtypes (STs) have been identified in
humans, other mammals, and birds. Among these sub-
types, ST1-ST4 collectively account for 90 % of human
carriage [6], while the ST5-ST9 account for the
remaining 10 %. To date ST9 has only been isolated
from humans [7]. To better understand the genetic di-
versity and determine the prevalence of Blastocystis sub-
types around the world, further research is required [8,
9]. The introduction of molecular screening assays such
as real-time polymerase chain reaction (RT-PCR) has
demonstrated that the prevalence of Blastocystis is much
higher than previously reported on the basis of detection
by conventional microscopy, in both developed [2, 9, 10]icle is distributed under the terms of the Creative Commons Attribution 4.0
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sity of Blastocystis in different hosts, age groups and gen-
ders, and in different regions of the world, is essential to
further our knowledge of the epidemiology and clinical
relevance of this organism.
In the past decade, Qatar has seen a fast-paced trans-
formation in the standards of living of its citizens. This tre-
mendous growth has spawned building and modernization
programs. There has been a large influx of migrant workers
into Doha to complete very ambitious and large-scale con-
struction projects. These workers mostly originate from
states in the Middle-East, Asia and Africa, the latter two
being regions where intestinal parasites are particularly
common [11, 12]. Economic growth has been accompan-
ied by rapidly expanding domestic services in the city,
which are also dependent on an immigrant labour force.
Improvements in the infrastructure have not kept pace
with this transformation, particularly the housing and
sanitation available for workers. The immigration policy in
Qatar applies a quota system to control the number of
workers entering Qatar each year according to their coun-
try of origin. This creates a dynamic population of workers
that changes from year to year and therefore requires con-
tinuous monitoring. On arrival in Qatar and before they
can obtain work permits, all new immigrants are obliged
to report to the Medical Commission for thorough med-
ical inspections but fecal examinations of all immigrant
workers seeking employment in the food industries and/
or as housemaids were abandoned following the introduc-
tion of compulsory treatment with albendazole, which is
effective mainly against helminths and not most protozoa
(although it does have activity against Giardia [13]). No
specific treatment is given for protozoan infections, so in
contrast to helminth infections these are not eradicated
from infected immigrants on arrival in Qatar. Once a
worker has been issued a work permit they are then not
obliged to undergo further health inspections unless they
work in the food industry, in which case annual re-
examination is mandatory. As foreign workers form an in-
tegral part of the food industry in Qatar, it is imperative to
determine their status as a potential reservoir and source
of infection for enteric pathogens. The same is true for
housemaids, who not only handle the food served to fam-
ilies, but also infants and children, who are generally more
susceptible to infection than adults.
As prevention is far more effective in the long-term than
cure, the identification of carriers and facilitation of the
medical management of individuals who shed these patho-
gens can be improved through the application of sensitive
screening methods, thereby minimizing the risk of infec-
tion spreading to other sectors of the community. In this
paper we report on the implementation of a molecular
screening assay (MSA) based on real-time PCR for the de-
tection and subtyping of Blastocystis in samples collectedfrom migrant workers newly arriving in Qatar, and we
compare the detection rate with that achieved by conven-
tional microscopy. We examine prevalence data for evi-
dence of regional variation, while controlling for age and
sex effects, and in a subset of the data we test whether the
prevalence of the different STs of Blastocystis differs be-
tween regions of origin of the carriers or is influenced by
host intrinsic factors, sex and age.
Methods
Sample collection and DNA extraction
We obtained stool samples from 608 randomly selected
immigrant workers (including food handlers, construc-
tion workers, and housemaids), arriving for the first time
in Qatar, and undergoing mandatory health checks at
the Medical Commission during their application for
work permits. Samples were collected in individually la-
belled, standard sterile disposable containers and were
immediately stored on ice until processed for DNA ex-
traction and microscopy.
Samples were aliquoted for DNA extraction alongside
conventional stool examination by microscopy. Micro-
scopic examination was carried out as described by
Abu-Madi and others [14]. DNA was extracted using the
QIAamp DNA stool minikit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions. Briefly,
samples were weighed, homogenized in lysis buffer, and
incubated at 95 °C for 5 min to ensure lysis of the tar-
geted protozoa. After centrifugation, the DNA in the
supernatant was purified using a silica column supplied
with the kit. The quantity and quality of the DNA was
determined using spectrophotometry (Nanodrop, Ther-
moScientific) and gel electrophoresis.
Ethical approval
Ethical approval for this project was obtained from the
Medical Research Centre and the Research Committee
at Hamad Medical Corporation, Qatar (Research proto-
col # 11110/11).
RT-PCR amplification and sequencing
To detect the presence of Blastocystis in the DNA ex-
tracted from the samples described above, well-studied
primers targeting the SSU rDNA region were used [10,
15, 16]. This region covers approximately 190 bp that are
highly specific for the SSU rDNAs of Blastocystis STs1-9,
but can also distinguish each ST. This approach has been
chosen over other possible approaches as the primer set
used is of diagnostic quality yet at the same time it ampli-
fies a product that will allow for subtyping once it is se-
quenced [15, 16]. DNA extracted from samples that were
positive for Blastocystis based on light microscopy was
used as a positive control. The reaction mixture contained
a final concentration of 0.3 μM of the primer set and
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7500 instrument. The reaction conditions were set as fol-
lowing: 95 °C for 5 min, and 50 cycles of denaturation at
95 °C for 15 s followed by annealing and extension at 60 °C
for 1 min.
Purified PCR products were sequenced using a Big-
Dye® Terminator v3.1 Cycle Sequencing Kit (Applied
Biosystems™ Austin, TX, USA). Thermal cycling was 96 °C
for 1 min, 40 cycles of (96 °C for 10 min, 50 °C for 5 s,
60 °C for 4 min) using either Blastocystis Fwd S1,
GGTCCGGTGAACACTTTGGATTT or Blastocystis
RvsS2, CCTACGGAAACCTTGTTACGACTTCA. Prod-
ucts were purified using XTerminator™ and SAM™ solu-
tions (Applied Biosystems™ Foster City, CA, USA) and
sequenced on a 3730xl DNA Analyzer (Applied Biosys-
tems™, Hitachi, Tokyo, Japan).
Genotyping analysis
To identify Blastocystis subtypes, both strands of the
amplicons were sequenced and were compared with all
the SSU rRNA gene sequences available from the Na-
tional Centre for Biotechnology Information (NCBI)
database using the BLAST program. SSU rDNA subtypes
were identified by determining the closest similarity match
against all known Blastocystis STs. All of our sequences
have been deposited in GenBank under Accession num-
bers KM438204-30.
Statistical analysis
Prevalence data are presented as percentages with
95 % confidence limits (95 % CL), calculated with be-
spoke software based on the tables of Rohlf and Sokal
[17]. Analysis comprised three stages. In the first we
compared detection of Blastocystis using the PCR method
with conventional detection by routine microscopy.
In the second step, we analyzed the factors affecting
prevalence of Blastocystis, based on detection of in-
fected subjects by PCR. For this analysis we used max-
imum likelihood techniques based on log linear analysis
of contingency tables in the software package IBM
SPSS Statistics Version 21 (IBM Corporation). Initially,
full factorial models were fitted, incorporating as factors
region of origin of subjects (REGION - 3 levels), sex of
subjects (SEX, 2 levels, male and female), and age of sub-
jects (AGE, 3 levels). The subjects (n = 608) originated
from 18 countries, but for statistical analysis were assigned
to three regions. Region 1, Africa comprised subjects from
Cameroon (n = 1), Egypt (2), Eritrea (3), Ethiopia (34),
Ghana (3), Kenya (27), Nigeria (15), Sudan (2), Chad (1)
and Uganda (1). Region 2, Eastern Asia comprised sub-
jects from Indonesia (119), Philippines (65), Thailand
(2) and Vietnam (2). Region 3, Western Asia, comprised
subjects from Bangladesh (71), India (117), Nepal (62) and
Sri Lanka (81). Subjects were allocated to three age classes(age class 1 = 18–29 years old, age class 2 = 30–39 years
old and age class 3 = 40–58 years old). The presence / ab-
sence of Blastocystis (INFECTION) was fitted as a binary
factor. These explanatory factors were fitted initially to all
models that were evaluated. For each level of analysis in
turn, beginning with the most complex model, involving
all possible main effects and interactions, those combina-
tions that did not contribute significantly to explaining
variation in the data were eliminated in a stepwise fashion
beginning with the highest level interaction (backward se-
lection procedure). A minimum sufficient model was then
obtained, for which the likelihood ratio of χ2 was not sig-
nificant, indicating that the model was sufficient to explain
the data. The importance of each term (i.e. interactions in-
volving infection) in the final model was assessed by the
probability that its exclusion would alter the model signifi-
cantly and these values relating to interactions that in-
cluded INFECTION are given in the text.
In stage three, analysis of the factors affecting the
prevalence of genotyped Blastocystis isolates was con-
ducted on the smaller data-set of sequenced isolates.
The subtype identification of a subset of 132 randomly
selected isolates was achieved by sequencing the SSU
rDNA. Some isolates (n = 18) were problematic and not
available for analysis because they could not be subtyped
successfully or were associated with missing data. How-
ever, 114 isolates were completely subtyped and analysed
for the current study. The successfully subtyped isolates
originated from donors ranging in age from 20 years to
a maximum of 56 years, with an average of 31.9 ± 0.75
(median of 30.0) years. Fifty three subjects were males
(mean age = 31.2 ± 1.13 and 61 females (mean age =
32.5 ± 0.99), and there was no significant difference be-
tween the ages of the two sexes (z = 1.055, P = 0.29).
The approach adopted for analysis was similar to that
in stage two of the analysis. Again subjects were allo-
cated to the same three regions and age classes. Three
models were fitted, one each for Blastocystis ST1, ST2
and ST3, and in each case with AGE, SEX and REGION
as explanatory factors and presence/absence of the sub-
type (INFECTION) as a binary factor. Reduction to mini-
mum sufficient models followed the same procedure as
that explained above in stage two of the analysis.
Throughout our cut-off for statistical significance was
P = 0.05.
Results
Prevalence of Blastocystis based on PCR method of
detection
Of the 608 samples tested by PCR for the presence of
Blastocystis, 432 were positive and 176 negative giving
an overall prevalence of 71.1 %. In contrast, microscopy
only identified 42 positives (6.9 % prevalence). Thirty
seven samples were identified as positive and 171 as
Table 2 The distribution of subtypes of Blastocystis among the
114 subjects by their countries of origin
Nationality n ST1 ST2 ST3
Africa 19
Cameroon 1 1 0 0
Chad 1 1 0 0
Eritrea 1 1 0 0
Ethiopia 12 7 0 5
Kenya 2 0 0 2
Nigeria 2 0 1 1
East Asian 31
Indonesia 19 6 3 10
Philippines 12 4 0 8
West Asia 64
Bangladesh 12 3 0 9
India 20 3 0 17
Nepal 16 1 0 15
Sri Lanka 16 4 0 12
114 31 4 79
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recorded as positive by microscopy but not detected as
such by PCR.
Factors affecting the prevalence of Blastocystis based on
detection by PCR
Analysis of the prevalence of Blastocystis based on PCR
revealed that neither host sex nor age affected preva-
lence significantly (Table 1). However, there was a highly
significant effect of the region from which subjects origi-
nated (REGION x INFECTION, χ22 = 16.1, p <0.001). In-
fections with Blastocystis were most common among
subjects from Africa and least common among those
from Eastern Asia, and the difference in prevalence be-
tween these regions was 20.0 %.
Subtype analysis and prevalence
Subtype analysis revealed that only three subtypes were
present in the samples analyzed. ST1 was present in 31
samples (27.2 %), ST2 was found in four hosts (3.5 %),
one from Nigeria and three from Indonesia, while 79
(69.3 %) samples had ST3. Interestingly, ST3 was found
in samples isolated from subjects of all geographical re-
gions included in the current study i.e. Africa, East and
West Asia. Table 2 shows the occurrence of subtypes
and strains among the 114 subjects by country of origin.
When the data were subdivided by the 12 countries of
origin of the subjects, some subsets became very small,
and indeed there was only one subject each from
Cameroon, Chad and Eritrea.
Factors affecting the prevalence of subtypes of
Blastocystis in subsets of the subjects in the study
In order to enable statistical analysis, the subjects were
allocated to three geographical regions (Tables 2 and 3).
There was no regional effect on ST1 and ST3, but with
age and host sex taken into account there was aTable 1 Factors affecting prevalence of Blastocystis, based on
detection by PCR
Factor Number Prevalence (%) 95 % CL
Host sex
Males 280 70.7 65.85–75.17
Females 328 71.3 66.10–76.10
Host age
Age class 1 (18–29) 286 73.1 68.25–77.42
Age class 2 (30–39) 233 70.0 65.49–74.10
Age class 3 (40–58) 89 67.4 54.32–78.65
Region of origin
Africa 89 87.6 76.54–94.08
Eastern Asia 188 67.6 57.95–75.86
Western Asia 331 68.6 63.23–73.49significant effect of region of origin on ST2 (REGION x
INFECTION, χ22 = 7.1, P = 0.029), despite the low preva-
lence of this ST among the 114 samples. This subtype
was not detected among the 64 W. Asian subjects
(Table 2). Table 3 shows that ST3 appeared to be more
common among W. Asian and ST1 among African sub-
jects, but with host sex and age taken into account these
differences in prevalence did not reach statistical signifi-
cance (effect of REGION on ST1, χ22 = 5.1, P = 0.078 and
on ST3, χ22 = 5.9, P = 0.052).
With region of origin and age taken into account,
there were significant effects of host sex on the preva-
lence of ST1 (Table 4; SEX x INFECTION, χ21 = 13.4, p
<0.001) and ST3 (Table 4; SEX x INFECTION, χ21 = 15.1,
p <0.001). In the case of ST1 the bias was strongly in
favour of female subjects with prevalence of this subtype
being 3.6-fold more common among females. ST3,
showed a bias in the opposite direction with prevalence
among male subject being 1.6-fold higher compared with
females.
With region of origin and host sex taken into account,
there were no significant effects of host age, although asTable 3 Prevalence of subtypes of Blastocystis among the three
regions of origin of the subjects in the study
Region n Subtype prevalence as a percentage (95 % CL)
ST1 ST2 ST3
Africa 18 52.6 (31.18–74.29) 5.3 (0.27–25.70) 42.1 (22.19–65.51)
East Asia 28 32.3 (20.18–46.45) 9.7 (3.77–21.51) 58.1 (43.81–71.40)
West Asia 64 17.2 (10.19–27.20) 0 (0–4.80) 82.8 (72.80–89.81)
Table 4 The influence of host sex and age on the prevalence
of ST1 and ST3
Subset ST1 ST3
% 95 % CL % 95 % CL
Males 11.3 6.12–19.43 86.8 78.52–92.57
Females 41.0 30.62–51.87 54.1 43.19–64.47
Age class 1 (18–29) 30.0 18.80–43.96 66.0 52.02–78.23
Age class 2 (30–39) 27.3 14.46–44.25 68.2 51.16–82.03
Age class 3 (40–58) 20.0 7.14–42.35 80.0 57.65–92.86
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decline in the prevalence of ST1 with increasing age and
an increase with age in the case of ST3.
Discussion
The results of our study show clearly that there is an
enormous difference in the detection of Blastocystis in
stool samples by microscopy vs PCR methodology.
Based on PCR methodology we concluded that 71.1 % of
the samples contained Blastocystis DNA, whilst conven-
tional microscopy detected only 42 positive samples, giv-
ing a prevalence of just 6.9 %. Higher detection rates of
intestinal protozoa, including Blastocystis, by PCR com-
pared with conventional microscopy have also been re-
cently reported in asymptomatic individuals from Brazil
[18], where microscopy detected 10 infected subjects out
of 126 (prevalence = 7.9 %) whereas PCR detected 43 in-
fections in the same subjects (prevalence = 34.1 %). This
difference in sensitivity of the two assays raises questions
about the utility of continuing to employ conventional
microscopy, when this method has such a high failure
rate in detecting the presence of this parasite. In this
study, as in our earlier work from Qatar, the stool sam-
ples were all screened by highly trained medical labora-
tory technicians and it is unlikely that any further
improvement is possible in the accuracy of detection by
microscopy. On this basis, we can confidently conclude
that earlier estimates of the prevalence of Blastocystis in
Qatar, which were all entirely based on microscopy [14],
were very heavily underestimated. Clearly, diagnostic mi-
croscopy of Blastocystis infections is generally less sensi-
tive than PCR-based methodology, resulting in marked
underestimation of the true prevalence of Blastocystis.
Our data showed that there was no difference in
prevalence between males and females both having
similarly high values for prevalence, although others
have found significant differences in prevalence be-
tween the sexes. Higher prevalence of Blastocystis in
male compared with female subjects has been observed,
for example, in Libya [19] and in China [20]. Participa-
tion in outdoor activities by the adult males, with the
associated higher risk of contamination by the faecal-
orally transmitted cysts of the parasite, has beenproposed as the underlying explanation. However, there
are examples also of bias in the opposite direction with
higher prevalence among female subjects, as for ex-
ample in Spain [21].
There was no difference in prevalence between the age
classes in our data, although there was a consistent, if
marginal, drift downwards with increasing age, which
was not statistically significant. Some earlier studies con-
cur with our results in failing to find any age effects on
the prevalence of Blastocystis. For example, no signifi-
cant associations were found between infections with
any of the observed Blastocystis STs and age classes in
Libya [22]. However, other studies have found signifi-
cantly higher infection rates in adults compared with
children, with the highest prevalence rate among asymp-
tomatic young adults aged between 18 and 30 years [23].
Trends in the opposite direction, with a higher preva-
lence rate in children compared to adults, have also been
reported, as for example in the Philippines [24]. In sup-
port of the latter, a recent study in Thailand has also re-
ported a significant reduction in the Blastocystis
infection with increasing age, the prevalence rate peak-
ing in the younger children in the study [25]. These con-
trasting findings suggest that the distribution of
Blastocystis infection among host populations shows
spatial heterogeneity with respect to host age and sex,
and these inconsistencies are most likely attributable to
local factors such as the environmental conditions that
influence locally the extent of, and the efficiency of, the
faecal-oral route of transmission among host sectors of
varying age, and between the two sexes [22].
The most prominent source of variation in prevalence
of Blastocystis that we detected was in the region of ori-
gin of the subjects, with immigrants from Africa show-
ing the highest prevalence and those from Eastern Asia,
comprising Indonesia and the Philippines, the lowest.
The prevalence of Blastocystis infection is known to vary
from country to country, as well as within countries [6].
However, it has been reported that a higher prevalence
occurs in developing countries than developed countries
[26–28]. Blastocystis is transmitted through the faecal-
oral route and among the most obvious risk factors are
poor personal and community hygiene, culture, and life-
style of a population. All of these vary from country to
country, partially depending on the economic status and
standard of living, but also on the geographical location
and climatic factors [29].
Because we used a PCR-based methodology for detec-
tion and successfully sequenced the PCR products, we
were also able to distinguish between different STs of
Blastocystis. Our results revealed some interesting trends
with respect to the influence of the region of origin on the
prevalence of STs but the only ST that was shown statisti-
cally to vary in relation to where the carrier originated
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jects from W. Asia. It should be noted that only four
samples in total were classified as this ST, and there-
fore we have to reserve judgement as to whether the
conclusion of a regional influence on the prevalence
of this ST is robust. Clearly further work must in-
clude a considerably larger sample size, to consolidate
or refute this finding.
The high prevalence of ST3 in our study population, es-
pecially among immigrants from Western Asia, is consist-
ent with other reports in the literature, as for example in
Thailand [30], Egypt [31], Singapore [26], Turkey [32, 33],
Germany [34], France [35], Malaysia [36], and Lebanon
[37]. In a recent study of the distribution of Blastocystis
subtypes in three African countries (Libya, Nigeria and
Liberia) by Alfellani et al. [6], four subtypes were detected
in the Libyan population with ST1 (50.0 %, 19/38) showing
the highest prevalence, followed by ST3 (39.5 %, 15/38),
ST2 (7.9 %, 3/38) and ST7 (2.6 %, 1/38). Other studies have
also identified ST1 as dominant among the examined out-
patients [19].
Perhaps the most interesting finding from our study,
was the marked sex-difference in the prevalence of ST1
and ST3, with ST1 being far more common among fe-
male subjects and subtype 3 more common among in-
fected males. Our finding of female bias with ST1 agrees
with a study in Libya where Blastocystis ST1 infection
was also significantly associated with females but was
linked also to a low educational level [19]. Nevertheless,
female sex-bias has not been detected in all studies. No
significant associations between sex and subtypes of Blas-
tocystis were found in Turkey [33, 34, 38]. The reasons for
these marked differences in the relative proportions of
subtypes between the sexes in affected populations are not
currently understood, but they most likely relate to differ-
ences between the sexes in cultural/traditional patterns of
behaviour and hence to different exposure rates to the
sources of transmission [39].Conclusions
On the basis of our results, we recommend that stool
screening via microscopy for the presence of Blastocystis
should be largely abandoned since it is extremely in-
sensitive even in the hands of the most experienced
technicians. In future, the detection of Blastocystis infec-
tions should be based on PCR methodology and we pre-
dict that in the years ahead diagnostic PCR will become
the tool of choice [40]. Our results have raised a number
of interesting issues that will be addressed in future
work, notably the underlying reasons for the regional
trends in the prevalence of the three STs of Blastocystis
that we detected in our study population, and for the
sex bias in the prevalence of ST1 and ST3.Competing interests
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